Pulmonary hypertension treatment: Future prospects

被引：5

作者：

Baloira, Adolfo ^{[1
]}

机构：

[1] Serv Neumol, Pontevedra 36001, Spain

来源：

ARCHIVOS DE BRONCONEUMOLOGIA | 2007年 / 43卷 / 03期

关键词：

D O I：

10.1157/13099528

中图分类号：

R56 [呼吸系及胸部疾病];

学科分类号：

摘要：

引用

页码：131 / 135

页数：5

共 44 条

[1] Medical therapy for pulmonary arterial hypertension - ACCP evidence-based clinical practice guidelines [J].

Badesch, DB ;

Abman, SH ;

Ahearn, GS ;

Barst, RJ ;

McCrory, DC ;

Simonneau, G ;

McLaughlin, VV .

CHEST, 2004, 126 (01) :35S-62S

[2] Role of platelet-derived growth factor in vascular remodeling during pulmonary hypertension in the ovine fetus [J].

Balasubramaniam, V ;

Le Cras, TD ;

Ivy, DD ;

Grover, TR ;

Kinsella, JP ;

Abman, SH .

AMERICAN JOURNAL OF PHYSIOLOGY-LUNG CELLULAR AND MOLECULAR PHYSIOLOGY, 2003, 284 (05) :L826-L833

[3] A comparison of continuous intravenous epoprostenol (prostacyclin) with conventional therapy for primary pulmonary hypertension [J].

Barst, RJ ;

Rubin, LJ ;

Long, WA ;

McGoon, MD ;

Rich, S ;

Badesch, DB ;

Groves, BM ;

Tapson, VF ;

Bourge, RC ;

Brundage, BH ;

Koerner, SK ;

Langleben, D ;

Keller, CA ;

Murali, S ;

Uretsky, BF ;

Clayton, LM ;

Jobsis, MM ;

Blackburn, SD ;

Shortino, D ;

Crow, JW .

NEW ENGLAND JOURNAL OF MEDICINE, 1996, 334 (05) :296-301

[4] Beraprost therapy for pulmonary arterial hypertension [J].

Barst, RJ ;

McGoon, M ;

McLaughlin, V ;

Tapson, V ;

Oudiz, R ;

Shapiro, S ;

Robbins, IM ;

Channick, R ;

Badesch, D ;

Rayburn, BK ;

Flinchbaugh, R ;

Sigman, J ;

Arneson, C ;

Jeffs, R .

JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2003, 41 (12) :2119-2125

[5] Effects of the dual endothelin-receptor antagonist bosentan in patients with pulmonary hypertension: a randomised placebo-controlled study [J].

Channick, RN ;

Simonneau, G ;

Sitbon, O ;

Robbins, IM ;

Frost, A ;

Tapson, VF ;

Badesch, DB ;

Roux, S ;

Rainisio, M ;

Bodin, F ;

Rubin, LJ .

LANCET, 2001, 358 (9288) :1119-1123

[6]

CHAPELIER A, 1993, J THORAC CARDIOV SUR, V106, P299

[7] SURVIVAL IN PATIENTS WITH PRIMARY PULMONARY-HYPERTENSION - RESULTS FROM A NATIONAL PROSPECTIVE REGISTRY [J].

DALONZO, GE ;

BARST, RJ ;

AYRES, SM ;

BERGOFSKY, EH ;

BRUNDAGE, BH ;

DETRE, KM ;

FISHMAN, AP ;

GOLDRING, RM ;

GROVES, BM ;

KERNIS, JT ;

LEVY, PS ;

PIETRA, GG ;

REID, LM ;

REEVES, JT ;

RICH, S ;

VREIM, CE ;

WILLIAMS, GW ;

WU, M .

ANNALS OF INTERNAL MEDICINE, 1991, 115 (05) :343-349

[8] Current concepts: Chronic thromboembolic pulmonary hypertension [J].

Fedullo, PF ;

Auger, WR ;

Kerr, KM ;

Rubin, LJ .

NEW ENGLAND JOURNAL OF MEDICINE, 2001, 345 (20) :1465-1472

[9] Serum N-terminal brain natriuretic peptide as a prognostic parameter in patients with pulmonary hypertension [J].

Fijalkowska, Anna ;

Kurzyna, Marcin ;

Torbicki, Adam ;

Szewczyk, Grzegorz ;

Florczyk, Michal ;

Pruszczyk, Piotr ;

Szturmowicz, Monika .

CHEST, 2006, 129 (05) :1313-1321

[10]

Fonseca JCC, 2005, ARCH BRONCONEUMOL, V41, P389

← 1 2 3 4 5 →